- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of OATP transporters on pharmacokinetics
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 158, Issue 3, Pages 693-705
Publisher
Wiley
Online
2009-09-28
DOI
10.1111/j.1476-5381.2009.00430.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
- (2010) Stefan Oswald et al. Pharmacogenetics and Genomics
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy
- (2008) Hiroshi Takane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interaction of Imatinib with Human Organic Ion Carriers
- (2008) S. Hu et al. CLINICAL CANCER RESEARCH
- Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes
- (2008) RM Franke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo
- (2008) A Tornio et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of Gemfibrozil and Atorvastatin on the Pharmacokinetics of Repaglinide in Relation to SLCO1B1 Polymorphism
- (2008) A Kalliokoski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3
- (2008) Chunshan Gui et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs
- (2008) Anne T Nies et al. Expert Opinion on Drug Metabolism & Toxicology
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
- (2008) Annikka Kalliokoski et al. Pharmacogenetics and Genomics
- The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
- (2008) Jian Wei Deng et al. Pharmacogenetics and Genomics
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes
- (2007) Hiroaki Yamaguchi et al. CANCER LETTERS
- Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
- (2007) Ji-Youn Han et al. LUNG CANCER
- Global analysis of genetic variation in SLCO1B1
- (2007) Marja K Pasanen et al. PHARMACOGENOMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started